Edit |   |
---|---|
Antigenic Specificity | ULBP2 (Center), 88-116 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.08 mL, 0.4 mL |
Concentration | vial concentration: 0.4 |
Applications | Western Blot (WB), ELISA (EIA) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This ULBP2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 88-116 amino acids from the Central region of human ULBP2. Ligand for the NKG2D receptor, together with at least ULBP1 and ULBP3. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. In CMV infected cells, interacts with soluble CMV glycoprotein UL16. The interaction with UL16 blocked the interaction with the NKG2D receptor, providing a mechanism by which CMV infected cells might escape the immune system. UL16 also causes U |
Immunogen | n/a |
Other Names | [NKG2D ligand 2; N2DL-2; NKG2DL2; ALCAN-alpha; Retinoic acid early transcript 1H; UL16-binding protein 2; ULBP2; N2DL2; RAET1H] |
Gene, Accession # | [ULBP2], Gene ID: 80328, NCBI: NP_079493.1, UniProt: Q9BZM5 |
Catalog # | MBS9202246 |
Price | $165, $370 |
Order / More Info | ULBP2 (Center), 88-116 Antibody from MYBIOSOURCE INC. |
Product Specific References | McGilvray, R.W., et al. Int. J. Cancer 127(6):1412-1420(2010) Nuckel, H., et al. Leukemia 24(6):1152-1159(2010) Antoun, A., et al. Hum. Immunol. 71(6):610-620(2010) Davila, S., et al. Genes Immun. 11(3):232-238(2010) Ward, J., et al. PLoS Pathog. 5 (10), E1000613 (2009) : |